Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol

Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol

Strongyloidiasis affects an estimated 600 million people worldwide, especially in tropical and subtropical areas. Single-dose ivermectin treatment has shown to be effective among immunocompetent patients with uncomplicated strongyloidiasis. Here, we present the protocol of the ImmunoStrong study, a...

Full description

Bibliographic Details
Main Authors: Fernando Salvador, Ana Lucas-Dato, Silvia Roure, Marta Arsuaga, Asunción Pérez-Jacoiste, Magdalena García-Rodríguez, José A. Pérez-Molina, Dora Buonfrate, José María Saugar, Israel Molina
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Pathogens
Subjects:
<i>Strongyloides stercoralis</i>
immunosuppression
ivermectin
PCR
population pharmacokinetics
Online Access:https://www.mdpi.com/2076-0817/10/7/812

Internet

https://www.mdpi.com/2076-0817/10/7/812

Similar Items